Zacks analysts give Orthofix shares a ‘strong buy’ rating — 4 quick facts

Zacks analysts gave Orthofix International a “strong buy” rating, according to Intercooler.

Advertisement

Here are four quick facts:

 

1. The analysts set a one-year consensus price target of $48 for Orthofix shares.  

 

2. For the current quarter, Zacks analysts predict Orthofix will post $0.16 earnings per share.

 

3. On Jan. 14, Orthofix shares opened at $39.23.

 

4. The company has a market cap of $741.02 million.

 

More articles on devices:
SeaSpine, K2M, Smith & Nephew & more: 19 key notes
DeGen Medical launches Hyper-C Anterior Cervical Plate System: 4 key notes
Medical Compression Systems seeks buyer: 3 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.